Characteristics and Potential Functions of Human Milk Adiponectin

Adiponectin is a protein hormone produced by adipose tissue, whose circulating levels are inversely related to adiposity and inflammation. Adiponectin circulates as oligomers, from the low-molecular-weight trimer to the high-molecular-weight octodecamer (18 mer). Each oligomer has distinct biologica...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of pediatrics Vol. 156; no. 2; pp. S41 - S46
Main Authors Newburg, David S., PhD, Woo, Jessica G., PhD, Morrow, Ardythe L., PhD
Format Journal Article Conference Proceeding
LanguageEnglish
Published Maryland Heights, MO Mosby, Inc 01.02.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Adiponectin is a protein hormone produced by adipose tissue, whose circulating levels are inversely related to adiposity and inflammation. Adiponectin circulates as oligomers, from the low-molecular-weight trimer to the high-molecular-weight octodecamer (18 mer). Each oligomer has distinct biological activities, which include enhancement of insulin sensitivity and metabolic control and suppression of inflammation. Adiponectin occurs in human milk at higher concentrations than leptin. The adiponectin in human milk is almost entirely of the high-molecular-weight form, the form with the highest activity in controlling many types of metabolic processes. Human adiponectin fed to infant mice is transported across the intestinal mucosa into the serum. An inverse relationship between adiponectin levels in milk and adiposity (weight-for-height) of the breast-fed infant was observed and could be due to modulation of infant metabolism by milk adiponectin and may be related to the observed protection against obesity by breast-feeding. Human milk may be a medium whereby the hormonal milieu (in response to internal factors and the environment) of the mother can be used to communicate with the breast-fed infant to modify infant metabolic processes. Transmission of information from mother to infant through milk may allow adaptation to fluctuating environmental conditions.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
David Newburg, PhD and Ardythe Morrow, PhD own shares of Glycosyn, Inc., and all potential conflicts of interest have been disclosed to the NIH and are being managed by Massachusetts General Hospital and Cincinnati Children's Hospital, respectively. Jessica Woo, Ph.D. has no affiliation with entitles having financial interests in the subject discussed in this article.
Author Disclosures
Mead Johnson Nutrition sponsored a symposium and provided an honorarium to participants. This review of the symposium presentation was written exclusively by the authors, who have no financial interests in production or sales of infant formula.
ISSN:0022-3476
1097-6833
DOI:10.1016/j.jpeds.2009.11.020